Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

Detected CMS Systems:

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. Social Networks
  10. External Links
  11. Libraries
  12. Hosting Providers
  13. CDN Services

We began analyzing https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2019.00170/full, but it redirected us to https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2019.00170/full. The analysis below is for the second page.

Title[redir]:
Frontiers | Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy
Description:
Background: Hypertrophic cardiomyopathy (HCM) is characterized by myocyte hypertrophy and fibrosis. Studies in 2 mouse models (R92W-TnT/R403Q-MyHC) at early ...

Matching Content Categories {📚}

  • Education
  • Science
  • Photography

Content Management System {📝}

What CMS is doi.org built with?


Doi.org is powered by TYPESETTER CMS.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 91,705,781 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We see no obvious way the site makes money.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Doi.org has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

cardiac, expression, hcm, myocytes, tgfβ, genes, gene, mouse, fibroblasts, google, scholar, doi, text, abstract, crossref, full, pubmed, data, control, human, mira, figure, compared, patients, heart, tnt, tgfb, profibrotic, weeks, tissue, age, rat, fibrosis, controls, littermate, myectomy, collagen, signaling, myhc, hypertrophic, cardiomyopathy, studies, mutant, redox, differences, myocyte, mutants, treatment, mirabc, mice,

Topics {✒️}

compensatory anti-hypertrophic/anti-fibrotic pathways tumour-suppressive mir-29a/b1 cluster ccaat/enhancer-binding protein-α pro-fibrotic/pro-hypertrophic tgfβ/et1 signaling renin receptor mannose-6-phosphate/insulin influences myosin-atpase activity anti-hypertrophic/anti-fibrotic genes data availability statement anti-hypertrophic/anti-fibrotic liver et1 + n-acetyl-l-cysteine pcr-amplified tail dna et1-mediated collagen deposition/fibrosis reactive oxygen species real-time rt-pcr human beta-cardiac myosin antifibrotic genes/pathways selectively renin-angiotensin-aldosterone system myosin heavy chain enhanced chemi-luminescence reagent current hgnc/ncbi nomenclature alpha-smooth muscle actin age/sex-matched donor hearts tgfβ2 suppress mir-29a tgfβ1/tgfβ2 suppressed mir-29a mir-29a-mimic prevented upregulation tgf-beta isoform upregulated pro-fibrotic target genes open-access article distributed pkc-dependent atf-2 activation antihypertrophic/antifibrotic genes/pathways et1-induced cardiac hypertrophy pro-fibrotic genes/pathways pro-fibrotic gene expression tgfβ-induced collagen expression renin-binding protein cellular stress response/fibrosis neonatal rat pups reduced cellular superoxide/h2o2 suppressed mir-29a expression hcm-var-risk model requiring heart transplantation supplementary material pro-hypertrophic et1 signaling neonatal rat hearts stimulated tgfβ expression/secretion hcm patient genotype/phenotype tgfβ-stimulated collagen expression mir-29a overexpression studies log2 fold-change compared research search frontiers

Schema {🗺️}

ScholarlyArticle:
      context:https://schema.org
      headline:Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy
      author:
            type:Person
            name:Yamin Liu
            affiliation:
               Division of Cardiology, Hypertrophic Cardiomyopathy Center of Excellence, University of California, San Francisco, United States
               Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, United States
            type:Person
            name:Junaid Afzal
            affiliation:
               Division of Cardiology, Hypertrophic Cardiomyopathy Center of Excellence, University of California, San Francisco, United States
               Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, United States
            type:Person
            name:Styliani Vakrou
            affiliation:
               Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, United States
            type:Person
            name:Gabriela V. Greenland
            affiliation:
               Division of Cardiology, Hypertrophic Cardiomyopathy Center of Excellence, University of California, San Francisco, United States
               Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, United States
            type:Person
            name:C. Conover Talbot
            affiliation:
               Johns Hopkins School of Medicine, Institute for Basic Biomedical Sciences, United States
            type:Person
            name:Virginia B. Hebl
            affiliation:
               Intermountain Medical Center, Intermountain Heart Institute, United States
            type:Person
            name:Yufan Guan
            affiliation:
               Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, United States
            type:Person
            name:Rehan Karmali
            affiliation:
               Division of Cardiology, Hypertrophic Cardiomyopathy Center of Excellence, University of California, San Francisco, United States
            type:Person
            name:Jil C. Tardiff
            affiliation:
               Sarver Heart Center, University of Arizona Health Sciences, United States
            type:Person
            name:Leslie A. Leinwand
            affiliation:
               Molecular, Cellular and Developmental Biology, Biofrontiers Institute, University of Colorado, United States
            type:Person
            name:Jeffrey E. Olgin
            affiliation:
               Division of Cardiology, Hypertrophic Cardiomyopathy Center of Excellence, University of California, San Francisco, United States
            type:Person
            name:Samarjit Das
            affiliation:
               Department of Anesthesia and Critical Care Medicine, Johns Hopkins University, United States
            type:Person
            name:Ryuya Fukunaga
            affiliation:
               Department of Biological Chemistry, Johns Hopkins School of Medicine, United States
            type:Person
            name:M. Roselle Abraham
            affiliation:
               Division of Cardiology, Hypertrophic Cardiomyopathy Center of Excellence, University of California, San Francisco, United States
               Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, United States
      datePublished:2019-12-17
      dateModified:2025-07-01
      publisher:
         type:Organization
         name:Frontiers
      isPartOf:
         type:PublicationIssue
         datePublished:2019
         isPartOf:
            type:PublicationVolume
            volumeNumber:6
            isPartOf:
               type:Periodical
               name:Frontiers in Cardiovascular Medicine
      citation:
         https://doi.org/10.3389/fcvm.2019.00170
      inLanguage:en
Person:
      name:Yamin Liu
      affiliation:
         Division of Cardiology, Hypertrophic Cardiomyopathy Center of Excellence, University of California, San Francisco, United States
         Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, United States
      name:Junaid Afzal
      affiliation:
         Division of Cardiology, Hypertrophic Cardiomyopathy Center of Excellence, University of California, San Francisco, United States
         Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, United States
      name:Styliani Vakrou
      affiliation:
         Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, United States
      name:Gabriela V. Greenland
      affiliation:
         Division of Cardiology, Hypertrophic Cardiomyopathy Center of Excellence, University of California, San Francisco, United States
         Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, United States
      name:C. Conover Talbot
      affiliation:
         Johns Hopkins School of Medicine, Institute for Basic Biomedical Sciences, United States
      name:Virginia B. Hebl
      affiliation:
         Intermountain Medical Center, Intermountain Heart Institute, United States
      name:Yufan Guan
      affiliation:
         Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, United States
      name:Rehan Karmali
      affiliation:
         Division of Cardiology, Hypertrophic Cardiomyopathy Center of Excellence, University of California, San Francisco, United States
      name:Jil C. Tardiff
      affiliation:
         Sarver Heart Center, University of Arizona Health Sciences, United States
      name:Leslie A. Leinwand
      affiliation:
         Molecular, Cellular and Developmental Biology, Biofrontiers Institute, University of Colorado, United States
      name:Jeffrey E. Olgin
      affiliation:
         Division of Cardiology, Hypertrophic Cardiomyopathy Center of Excellence, University of California, San Francisco, United States
      name:Samarjit Das
      affiliation:
         Department of Anesthesia and Critical Care Medicine, Johns Hopkins University, United States
      name:Ryuya Fukunaga
      affiliation:
         Department of Biological Chemistry, Johns Hopkins School of Medicine, United States
      name:M. Roselle Abraham
      affiliation:
         Division of Cardiology, Hypertrophic Cardiomyopathy Center of Excellence, University of California, San Francisco, United States
         Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, United States
Organization:
      name:Frontiers
PublicationIssue:
      datePublished:2019
      isPartOf:
         type:PublicationVolume
         volumeNumber:6
         isPartOf:
            type:Periodical
            name:Frontiers in Cardiovascular Medicine
PublicationVolume:
      volumeNumber:6
      isPartOf:
         type:Periodical
         name:Frontiers in Cardiovascular Medicine
Periodical:
      name:Frontiers in Cardiovascular Medicine

Social Networks {👍}(7)

External Links {🔗}(316)

Libraries {📚}

  • Backbone.js
  • Vue.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Cloudflare
  • Crossref

6.01s.